News

The expansion will add 1858m² of space and associated equipment and support cell line construction, upstream and downstream process development, and a range of analytical services. The expanded

VEGF Trap-Eye, a human fusion protein consisting of portions of VEGF receptors 1 and 2, binds all forms of VEGF-A along with the related Placental Growth Factor (PlGF).

A PhD student with the Department of Cardiovascular Sciences Hussein Rubaiy analyzed the mechanisms of a cardiac potassium channel and its component parts, which play an important role

The company has already started distribution of the Zolpidem Tartrate Extended-Release Tablets, the generic equivalent of Ambien CR. Sanofi-aventis’ Ambien CR is indicated for the treatment of insomnia

PROLOR Biotech uses patented CTP technology and its Reversible PEGylation technology to develop longer-acting, proprietary versions of already approved therapeutic proteins to increase half-life of the drug candidate.

The agreement has been signed between Durata and one of the manufacturers who were involved in dalbavancin manufacturing. Dalbavancin is an intravenous (IV) lipoglycopeptide used to treat of

The STOP-TBI trial aims to investigate the safety, efficacy and dosing parameters of a novel perfluorocarbon emulsion, Oxycyte PFC that is given intravenously to traumatic brain injury patients.

As per the terms of the agreement, Pharming is entitled to receive certain commercial, regulatory and clinical milestones from MegaPharm. MegaPharm will buy its commercial supply of Ruconest

Avonex Pen (Avonex 30mcg/0.5ml solution for injection, in pre-filled pen) is a single-use, once-a-week, intramuscular autoinjector which includes a protective injector shield that conceals the needle prior to